Mediated Microenvironmental Modulation Targeting Osteoclasts for ONFH Niche Reprogramming" has been published in ...
With AI tools, it's now as easy as one, two, three to generate professional voiceovers with adjustable pitch, tone, pacing, and transform static slides into immersive experiences. These latest 2026 ...
Amgen (NasdaqGS:AMGN) and Kyowa Kirin have stopped all clinical trials of rocatinlimab after newly identified safety concerns. The companies cited potential links between OX40 pathway modulation and ...
Luckily, there are other concoctions to fend off sickness this season that are easy to make at home, including fire cider, a ...
EET Espoo, Finland, March 5, 2026: Herantis Pharma Plc ("Herantis") a clinical-stage company developing disease-modifying therapies to stop the progression of Parkinson’s disease, releases today the ...
Semtech Corporation (Nasdaq: SMTC), a leading provider of high-performance semiconductor, Internet of Things (IoT) systems ...
Semtech acquires HieFo Corporation for $34M, adding InP technology to its AI data center portfolio. Read about this major ...
Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized by progressive cognitive decline and ...
Company announcement Herantis Pharma Plc | Company Release | March 5, 2026 at 08:00 EET Herantis Pharma releases 2H and FY 2025 report today Espoo, Finland, March 5, 2026: Herantis Pharma Plc ("Herant ...
A pre-clinical biopharmaceutical company dedicated to precision cardiology through targeted RNA therapeutics designed to ...
Digital Silk, an award-winning agency focused on creating brand strategies, custom websites, and digital marketing campaigns, partnered with Productside to execute a strategic website redesign that ...
Discusses Clinical Progress of Bezisterim Targeting Inflammation in Parkinson's, Alzheimer's, and Long COVID March 4, 2026 4:15 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results